PubMed Health⌕ Search

PubMed · 11704441

A sequential neural network model for diabetes prediction.

Abstract

This paper presents a neural network (NN) model to evaluate an existing Health Risk Appraisal (HRA) for diabetes prediction over 3 years (1996-1998) based on a simulated learning algorithm on individual prognostic process, using the repeatedly measured HRAs of 6142 participants. The approach uses a sequential multi-layered perceptron (SMLP) with backpropagation learning, and an explicit model of time-varying inputs along with the sequentially obtained prediction probability, which was obtained by embedding a multivariate logistic function for consecutive years. The study captures the time-sensitive feature of associating risk factors as predictors to the occurrence of diabetes in the corresponding period. This approach outperforms the baseline classification and regression models in terms of gains (average profit: 0.18) and sensitivity (86.04%) for a test data. The result enables a time-sensitive disease prevention and management program as a prospective effort.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Park, D W Edington. 2001. A sequential neural network model for diabetes prediction.. https://doi.org/10.1016/s0933-3657(01)00086-0

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.

The purification of animal insulin preparations and the use of human recombinant insulin have markedly reduced the incidence but not completely suppressed the occurrence of insulin allergy manifestations. Advances in technologies concerning the mode of delivery of insulin, i.e. continuous subcutaneous insulin infusion (CSII), and the use of insulin analogues, resulting from the alteration in the amino acid sequence of the native insulin molecule, may influence the immunogenicity and antigenicity of native insulin. Instead of increasing allergy reactions, CSII has been reported to represent a successful alternative treatment in diabetic patients presenting local or generalized allergy to insulin or other components (zinc, protamine) of conventional treatment. Most recent reports concern CSII-treated patients using short-acting insulin analogues (essentially insulin lispro), although the precise role of these insulin analogues remains unclear as allergy to them has also been described. Finally, data on antigenicity and immunogenicity of long-acting insulin analogues (glargine, detemir), which may mimic the basal insulin delivery with CSII, remain scarce at present.

Diabetes Mellitus↗

Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.

Insulin deficiency is known to be associated with a state of increased muscle protein breakdown; this process is mediated by the ubiquitin-proteasome pathway. Convincing in vitro data are further supported by extensive studies in humans with insulin deprivation and are further substantiated by reversal of muscle protein breakdown with insulin treatment. In patients with end-stage renal disease (ESRD) and diabetes mellitus (DM), muscle protein breakdown is enhanced in both acute and chronic conditions. Recent data also point to the potential protein catabolic effects of insulin resistance combined with insulin deficiency. Because ESRD is associated with a state of insulin resistance, uremic muscle wasting may also be mediated by this pathway.

Diabetes Mellitus↗